How much funding has Mariana Oncology raised?

Mariana Oncology has raised $250.0M in total funding, most recently a Series B round.

Who are Mariana Oncology's investors?

Mariana Oncology's investors include Atlas Venture, Novartis Venture Fund, Deep Track Capital, Forbion Capital Partners.

When was Mariana Oncology founded?

Mariana Oncology was founded in 2021.

Where is Mariana Oncology headquartered?

Mariana Oncology is headquartered in United States.

What industry is Mariana Oncology in?

Mariana Oncology operates in Biotech, Healthcare.

How many employees does Mariana Oncology have?

Mariana Oncology has 11-50 employees.

Mariana Oncology

Acquired

United States · Founded 2021 · $250.0M raised

Biotech

Healthcare

Employees: 11–50
Founded: 2021
Business Model: B2B
Website: marianaoncology.com

Total Funding: $250.0M
Last Round: $175.0M Series BSep 2023
Rounds: 2

About

Mariana Oncology, now a Novartis company, was a preclinical-stage biotechnology company focused on developing next-generation radioligand therapies (RLTs) to treat solid tumor cancers. The company built a portfolio of novel peptide-based radiopharmaceuticals designed to selectively deliver radioisotopes to diseased cells while minimizing damage to healthy tissue. Founded in 2021, Mariana raised $175M in a Series B round in 2023 before being acquired by Novartis for $1 billion in 2024.

Summary

Mariana Oncology is a Biotech company based in United States, founded in 2021. It has raised $250.0M in total across 2 rounds, most recently a $175.0M Series B round in Sep 2023. Investors include Atlas Venture, Novartis Venture Fund and Deep Track Capital.